The efficacy of hydrogen eye drop for retinal artery occlusion

The efficacy of hydrogen eye drop for the ischemia-reperfusion injury of retinal artery occlusion

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs031180280

Enrollment

Registered

2019-03-14

Start date

2014-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal artery occlusion Retinal artery occlusion

Interventions

hydrogen eye drop. Apply to the eye. 50ml/min, 20mins, Total 1,000ml

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient of retinal arterial occlusion

Exclusion criteria

Exclusion criteria: Patients without thrombolytic therapy

Design outcomes

Primary

Measure	Time frame
visual acuity, retinal optical coherence tomography	—

Secondary

Measure	Time frame
Arm-to-retina circulation time by fluorescein angiography, Static visual field, Retinal electrogram	—

Contacts

Public ContactTsutomu Igarashi

Nippon medical school chiba hokusoh hospital

tutomu@nms.ac.jp+81-476-99-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026